Likewise, primary TNBC patients’ tumor samples (CRDCA, SEM‐1, and ARI‐1) also showed increased expression of E‐cadherin, active β‐catenin, and ALDH but decreased expression of YAP and CD44 (Fig. 5C, Fig. S6). The gene discussed is CDH1; the disease is neoplasm.